BINEX Co., Ltd. (KOSDAQ:053030)
17,330
+670 (4.02%)
Sep 19, 2025, 3:30 PM KST
BINEX Market Cap
BINEX has a market cap or net worth of 551.92 billion as of September 19, 2025. Its market cap has decreased by -24.54% in one year.
Market Cap
551.92B
Enterprise Value
622.64B
Revenue
153.18B
Ranking
n/a
PE Ratio
n/a
Stock Price
17,330.00
Market Cap Chart
Since March 1, 2002, BINEX's market cap has increased from 25.29B to 551.92B, an increase of 2,082.71%. That is a compound annual growth rate of 13.98%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 19, 2025 | 551.92B | -5.51% |
Dec 30, 2024 | 584.09B | 111.03% |
Dec 28, 2023 | 276.77B | -22.51% |
Dec 29, 2022 | 357.18B | -24.01% |
Dec 30, 2021 | 470.05B | -43.25% |
Dec 30, 2020 | 828.30B | 236.18% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.24T |
Celltrion | 37.10T |
ALTEOGEN | 25.28T |
Yuhan | 8,752.85B |
SK Biopharmaceuticals | 8,410.84B |
Peptron | 6,744.58B |
PharmaResearch | 6,431.19B |
ABL Bio | 5,452.05B |